Dian-Shuai Gao Selected Research

Glial Cell Line-Derived Neurotrophic Factor (GDNF)

5/2021	Possible role of glial cell line-derived neurotrophic factor for predicting cognitive impairment in Parkinson's disease: a case-control study.
12/2020	Down-Regulated CUEDC2 Increases GDNF Expression by Stabilizing CREB Through Reducing Its Ubiquitination in Glioma.
3/2020	MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling.
1/2019	Golgin-160 and GMAP210 play an important role in U251 cells migration and invasion initiated by GDNF.
7/2018	Cross-link regulation of precursor N-cadherin and FGFR1 by GDNF increases U251MG cell viability.
10/2017	Glucose-6-phosphatase-α participates in dopaminergic differentiation.
9/2017	Neuropilin-1 is a glial cell line-derived neurotrophic factor receptor in glioblastoma.
7/2017	Egr-1 and RNA POL II facilitate glioma cell GDNF transcription induced by histone hyperacetylation in promoter II.
1/2017	MiRNAs Mediate GDNF-Induced Proliferation and Migration of Glioma Cells.
1/2016	An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dian-Shuai Gao Research Topics

Disease

12	Glioma (Gliomas) 12/2020 - 12/2013
5	Parkinson Disease (Parkinson's Disease) 05/2021 - 10/2013
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 12/2014
2	Neuroblastoma 03/2020 - 10/2017
2	Neoplasms (Cancer) 01/2019 - 07/2016
2	Astrocytoma (Pilocytic Astrocytoma) 01/2016 - 11/2014
1	Cognitive Dysfunction 05/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2018
1	Inflammation (Inflammations) 01/2017
1	Demyelinating Diseases (Demyelinating Disease) 01/2017
1	Diabetes Complications 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2013
1	Pathologic Processes 05/2013
1	Primary Ovarian Insufficiency 05/2013

Drug/Important Bio-Agent (IBA)

14	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2021 - 10/2013
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2013
3	MicroRNAs (MicroRNA)IBA 10/2017 - 09/2013
3	Histones (Histone)IBA 07/2017 - 11/2014
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 12/2020 - 12/2013
2	Pharmaceutical PreparationsIBA 03/2020 - 05/2013
2	Messenger RNA (mRNA)IBA 10/2017 - 12/2013
1	Transcription Factors (Transcription Factor)IBA 12/2020
1	Oxidopamine (6 Hydroxydopamine)IBA 03/2020
1	NeurotoxinsIBA 03/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	ChloridesIBA 10/2018
1	Cadherins (E-Cadherin)IBA 07/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2017
1	Neuropilin-1IBA 09/2017
1	RNA Polymerase II (RNA Polymerase B)IBA 07/2017
1	Retinaldehyde (Retinal)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Advanced Glycation End ProductsIBA 01/2017
1	ChemokinesIBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Capsaicin (Zostrix)FDA Link 07/2016
1	ChromatinIBA 12/2014
1	Lysine (L-Lysine)FDA Link 11/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2013
1	Biological ProductsIBA 05/2013
1	Cell Surface ReceptorsIBA 05/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2013

Therapy/Procedure

2	Therapeutics 10/2017 - 08/2016
1	Drug Therapy (Chemotherapy) 01/2019
1	Transplantation 01/2017